Illinois News Joint

MARCH 11, 2024

MCAB board members took preliminary votes to include two qualifying debilitating conditions for medical cannabis patients in Illinois. Mulvehill introduced Illinois resident Gabriella Bova, who also advocated for including FOD as debilitating condition for medical patients. I dealt with the sexual shame and stigma of having FOD.

Conditions 84

Conditions Advocacy Patients Programs 84

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). Patient-reported outcomes. PROGRAMME.and.ABSTRACTS.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

MMJ Recs

MARCH 6, 2024

Discover how legalization and regulation have influenced access and usage, and learn about the latest research and medical applications. Conversely, some states opted for more conservative medical-only programs, tightly regulating patient access and product availability.

Marijuana 52

Marijuana Chronic Pain Patients Treatment 52

Cannabis Law Report

MAY 12, 2022

Aurora Cannabis announced today that they will be launching a new product line for patients in the United Kingdom. Still, only a small number of patients actually get medical cannabis prescriptions and accessibility is still a hot button issue in the country.

Terpenes 52

Terpenes Extraction Advocacy Patients 52

United Patients Group

APRIL 14, 2023

Cannabis and Hunger Cannabis contains over 100 + active compounds called cannabinoids that interact with the body’s endocannabinoid system. The two primary cannabinoids found in cannabis are tetrahydrocannabinol (THC) and cannabidiol (CBD). appeared first on United Patients Group.

THC 52

THC Strains Research and Development Patients 52

Veriheal

NOVEMBER 4, 2021

In 2018, a rule limiting MMJ doctors in the state to 100 patients or less was eliminated , expanding the availability of MMJ for state residents. Edwards signed a bill in June allowing medical patients access to cannabis flower rather than just concentrates, which will go into effect in January 2022. Starting Aug.

Law 102

Law Decriminalization Advocacy Programs 102

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. Substances derived from the cannabis plant include marijuana, hemp, and cannabinoids. Executive Summary.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

NORML

AUGUST 26, 2019

Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. And, 2019’s SB 1557 makes it possible for patients to get as much as 10mg of THC in each dose — the same limit as one serving size for edibles in adult-use states.

Marijuana 211

Marijuana Legalization Programs Oil 211

MMJ Recs

MARCH 16, 2024

Changes in regulations can have ripple effects throughout the industry, impacting supply chains, investment strategies, and consumer access to medical cannabis products. Key factors influencing market size and revenue include patient demographics, regulatory frameworks, product offerings, and pricing strategies.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Veriheal

MAY 19, 2021

However, in most cases, this involves the strength of products and the content of various cannabinoids such as CBD and THC. However, in recent weeks and months, there has been another cannabinoid entering the scene, making waves for many reasons. This cannabinoid is Delta 8 THC , and the questions people have regarding it are abundant.

THC 104

THC Cannabinoids Hemp Concentrates 104

MMJ Recs

DECEMBER 22, 2023

Public discourse became more nuanced, with patients and advocacy groups championing the cause of medical marijuana as a legitimate and effective treatment option. One of the key drivers of this shift is the increasing body of scientific research highlighting the medical properties of cannabinoids, the active compounds in marijuana.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Veriheal

FEBRUARY 4, 2022

The state’s leading physician advocacy group, the Vermont Medical Society , initially issued the rejected recommendations to the Cannabis Control Board. Interestingly, medical cannabis products in Vermont are not restricted based on their level of cannabinoid potency. However, many of these myths have already been dispelled.

THC 96

THC Decriminalization Cannabis Concentrates 96

NORML

JANUARY 2, 2019

Thus every pound of cannabis which is donated free of charge to legal patients is liable for nearly $1000 in state taxes.”. Grower Advocacy Council and the Mass. Patient Advocacy Alliance to Host Second Annual Harvest Cup. “We Dan Viets says it will still be until next year for people to access cannabis.

Advocacy 128

Advocacy Decriminalization Legislation Cultivation 128

SpeedWeed

APRIL 2, 2021

The name of the event is a reference to the Realm of Caring (RoC), a nonprofit dedicated to supporting research into cannabinoids and helping patients who need them gain access to lifesaving medications. She was the sort of patient zero, if you will,” Jackson said in a virtual interview. “So She was the catalyst.

Events 52

Events Epilepsy Cannabinoids Treatment 52

The Cannigma

JANUARY 19, 2022

The resulting prejudice can often discourage folks from seeking out medical cannabis as an option, and can even affect state legislature, forcing patients to overcome unnecessary and prohibitive obstacles in order to receive the treatment they need. The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access.

Patients 83

Patients Compliance Compliance Cannabis 83

Peninsula Alternative Health

MARCH 1, 2018

The common mission of these nonprofits and trade associations is to educate on the benefits of medical cannabis and create legislative change for businesses, physicians, and qualifying patients. Check out this comprehensive list by Peninsula Alternative Health in Salisbury, Maryland: Americans for Safe Access (ASA).

Treatment 40

Treatment Education Advocacy Access 40

Peninsula Alternative Health

MARCH 1, 2018

The common mission of these nonprofits and trade associations is to educate on the benefits of medical cannabis and create legislative change for businesses, physicians, and qualifying patients. Check out this comprehensive list by Peninsula Alternative Health in Salisbury, Maryland: Americans for Safe Access (ASA).

Treatment 40

Treatment Education Advocacy Access 40

Veriheal

DECEMBER 1, 2020

Cannabinoid science is an area that is rapidly advancing across the United States. THC is the prominent intoxicating cannabinoid in cannabis that we know of. An outdated study from the early 1990s conducted on chemotherapy patients that were children showed just like Delta-9 that Delta-8 helped prevent vomiting.

THC 52

THC DEA Research and Development Cannabinoids 52

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Program between St. Bonaventure University and George Washington University School of Medicine. .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. The review, however, did not cover patient access to medicinal cannabis. 2016 ; Sznitman et al.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 12, 2021

Recent shifting attitudes towards the medical use of cannabis has seen legal access pathways established in many jurisdictions in North America, Europe and Australasia. Others who need to drive are excluded from accessing a needed medication and associated therapeutic benefit. Background. Conclusion. S0955395921002127-main.

Policy 66

Policy Safety Medicine Access 66

Cannabis Law Report

MAY 18, 2022

The first cohort of the study , which was peer-reviewed and published in Cannabis and Cannabinoid Medicine last year, observed 839 individuals taking CBD produced by twelve companies with the primary end point being liver function. Hemp Roundtable, the hemp industry’s national advocacy organization. “The

Safety 52

Safety Hemp Research and Development Data 52

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

Cannabis Law Report

MAY 18, 2022

The first cohort of the study , which was peer-reviewed and published in Cannabis and Cannabinoid Medicine last year, observed 839 individuals taking CBD produced by twelve companies with the primary end point being liver function. Hemp Roundtable, the hemp industry’s national advocacy organization. “The

Safety 52

Safety Hemp Research and Development Data 52

SpeedWeed

MAY 27, 2021

LEUNE launched on Eaze in 2019 as an accessible preroll and vaporizer brand. Founded by Cynthia Boedihardjo and Sharp in 2017, Nouera began as an entertainment company that sought to elevate social events by pairing them with cannabis and making them more accessible to women. Timeka Drew, Co-Founder Biko.

Strains 52

Strains History Dispensary Cannabis 52

The Cannigma

APRIL 7, 2022

We’ve got our regular segment with our Co-produces on this podcast with Americans for Safe Access. I was going to live at a place he was buying an Eagle Rock and this guy from Berkeley came in, Don Duncan, who had helped start Berkeley Patients Group and was going to open up LAPCG in Los Angeles. CP: Let’s get to it.

Terpenes 52

Terpenes Wellness and Beauty Cannabis Extraction 52

SpeedWeed

APRIL 3, 2021

After years of tireless advocacy and extraordinarily hard work, that time is coming to an end in New York state,” Cuomo said. . “For generations, too many New Yorkers have been unfairly penalized for the use and sale of adult-use cannabis, arbitrarily arrested and jailed with harsh mandatory minimum sentences.

Legislation 40

Legislation Retail Programs Cannabis 40

SpeedWeed

APRIL 3, 2021

After years of tireless advocacy and extraordinarily hard work, that time is coming to an end in New York state,” Cuomo said. . “For generations, too many New Yorkers have been unfairly penalized for the use and sale of adult-use cannabis, arbitrarily arrested and jailed with harsh mandatory minimum sentences.

Programs 52

Programs Cultivation Legislation Retail 52

NORML

MAY 1, 2019

David Phipps, communications director of Indiana Norml, said CBD oil can help with epilepsy, noting cases where some child patients went from over 100 seizures a day to near zero when they started taking CBD.” Many of them are patients, and more than a handful have been in Maricopa County.” ” Read more from News One

Decriminalization 166

Decriminalization Seed-To-Sale Marijuana Patients 166

The Cannigma

FEBRUARY 16, 2022

So, with that, we should get into it, but don’t forget to check out our segment with Americans for Safe Access. We always have a nice little tidbit when we’re all about advocacy and access to cannabis for all. So, this is hot news right now, cannabinoid acids. Let’s listen to Steven.

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73

Cannabis Law Report

JUNE 4, 2021

Sessa is also the Chief Medical Officer of Awakn Life Sciences, and has been a part of scientific and clinical studies administering LSD, psilocybin, ketamine, MDMA and DMT to patients and volunteers. Healing Advocacy Fund. Brian Muraresku. in/andrew-chadeayne-989b751/ [link]. Sam Chapman. in/sam-chapman-0a0a8229/ [link]. Bruce Tobin.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51